NRXS -
Neuraxis, Inc.
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 2.46 0.19 (7.72%) |
--- |
--- |
0.02 (0.76%) |
0.0 (0.0%) |
0.14 (5.58%) |
-0.24 (-9.7%) |
-0.04 (-1.6%) |
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Earnings & Ratios
- Basic EPS:
- -0.22
- Diluted EPS:
- -0.22
- Basic P/E:
- -12.0455
- Diluted P/E:
- -12.0455
- RSI(14) 1m:
- 44.44
- VWAP:
- 2.65
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
Oct 24, 2025 12:00
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
May 05, 2025 13:00
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
Mar 12, 2025 13:00
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
Jan 21, 2025 18:45
NeurAxis Inc. Issues Letter to Shareholders
Jan 13, 2025 14:00
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Jan 06, 2025 14:00
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Sep 19, 2024 13:00
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
Aug 13, 2024 13:00
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
Jun 07, 2024 13:00
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
May 15, 2024 20:30